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Abstract
Background: Chronic non-healing wounds present a substantial economic burden to healthcare system;
significant reductions in quality of life for those affected, and precede often serious events such as limp
amputations or even premature deaths. This burden is also likely to increase with a larger proportion of
elderly and increasing prevalence of life-style diseases such as obesity and diabetes. Reviews of the evidence
on the burden of illness associated with chronic wounds have not been comprehensive in scope and have
not provided an assessment of the distribution of the health care costs across categories of resource use.
Methods/design: This study is a systematic review of multiple databases for studies on adult patients with
chronic wounds and with the primary objective to assess the impact on health-related quality of life by
category of ulcers, and associated direct and indirect costs. Eligible studies will primary be empirical studies
evaluating, describing or comparing measurement of quality of life and economic impact. Two reviewers will
independently screen titles and abstracts and select studies involving adults with chronic wounds. These
investigators will also independently extract data using a pre-designed data extraction form. Differences in
applied methodologies and uncertainties will clearly be accounted for. Conservative valuations of costs and
impact on health-related quality of life will be prioritised. Variations that may depend on age distribution, the
categorisation of ulcer, healthcare system etc. will be described clearly.
Discussion: The proposed systematic review will yield a comprehensive assessment of the humanistic and
economic burden of chronic wounds in an adult population. A better understanding of the humanistic and
economic burden of chronic wounds is essential for policy and planning purposes, to monitor trends in
disease burden and not at least in order to estimate the real-world cost-effectiveness of new treatments and
therapies.
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Keywords: Chronic wounds, Hard-to-heal ulcers, Quality of life, Health-related quality of life, Quality-adjusted
life years, Cost of illness, Costs and cost analysis, Economics
* Correspondence: josip.car@imperial.ac.uk; josip.car@ntu.edu.sg
1Centre for Population Health Sciences (CePHaS), Lee Kong Chian School of
Medicine, Nanyang Technological University, 59 Nanyang Drive, Experimental
Medicine Building, Singapore 636921, Singapore
5Global eHealth Unit, Department of Primary Care and Public Health, School
of Public Health, Imperial College London, 3rd Floor Reynolds Building, St
Dunstan’s Road, London W6 8RP, UK
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Järbrink et al. Systematic Reviews  (2017) 6:15 
DOI 10.1186/s13643-016-0400-8
Background
A chronic wound can be defined as one that has failed
to proceed through an orderly and timely reparative
process to produce anatomic and functional integrity
within a period of 3 months or that has proceeded
through the repair process without establishing a sus-
tained and anatomic and functional result [1, 2]. The no-
menclature is far from agreed upon, and these wounds
are sometimes referred to as hard-to-heal or difficult to
heal wounds/ulcers, and the time span required for
chronicity has been defined in the range from 4 weeks
up to more than 3 months [2–4]. Based on the causative
aetiologies, the Wound Healing Society classifies chronic
wounds into four categories: pressure ulcers, diabetic ul-
cers, venous ulcers and arterial insufficiency ulcers [5].
Older people are the highest risk group for chronic
wounds given that wound repair slows down as the body
ages [6, 7] and incidences of cardiovascular disease and
diabetes (which increase the incidence of chronic
wounds) also increase with age [8]. The basic biology
and the influence of age-associated changes on wound
healing are poorly understood, and there are numerous
research questions still to be answered [7].
Wounds are typically managed as a co-morbidity of
other conditions, limiting the impact of efforts to over-
come the growing challenge they represent. Clinicians
often lack specialised training in the diagnosis and treat-
ment of wounds because it is not a defined specialisation
and different specialists such as dermatologists, podia-
trists, endocrinologists, vascular surgeons and geriatri-
cians, maybe involved in the care to a different extent in
different healthcare systems. From a policy perspective,
this fragmented responsibility has led to a lack of priori-
tisation of resources and capabilities around wound care,
and in a clinical sense has produced inconsistent treat-
ments, prolonged healing and an uncoordinated ap-
proach to prevention [9]. It is a ‘silent epidemic’ [10],
and this has often resulted in inadequate planning and
poor implementation of prevention, treatment and man-
agement strategies. Consequently, wound research is an
important but neglected field. The lack of research has
compromised innovation in new therapies, diagnostics,
clinical practices and procedures. For example, the sci-
entific literature highlights the lack of knowledge on the
biological processes associated with wound healing and
limited evidence for effective pathways of clinical care
and therapies for prevention and healing [11].
Although wound care is a multibillion-dollar world-
wide problem, that only in the USA affect 5.7 million
people (~2% of population) at an annual cost of US$20
billion [12]. A UK report suggested that treatment and
care of chronic wounds accounts for 3% of total health-
care expenditure in developed countries [13], but this is
probably somewhat low because a more recent study
from Wales using estimates of prevalence and cost
from routine NHS data concludes that chronic
wounds have a prevalence of 6% and consume at least
5.5% of NHS expenditure [14].Chronic non-healing
wounds would thereby impose an immense financial
burden to the society, not only through an economic
burden on the health care system but also through a
reduction in productivity [15].
Chronic wounds may require several years to heal, and
some remain unhealed for decades. During this time, pa-
tients can experience severe pain, significant emotional
and physical distress, reduced mobility and social isola-
tion [16]. Studies have also shown that chronic wounds
not only cause severe emotional and physical trauma to
the patient but also to their families [17]. Chronic
wounds may also result in disabilities after all available
therapeutic interventions have been exhausted, and an
amputation is necessary. Ulcers precede 85% of all am-
putations [18] while diabetic ulcer is the reason for 70%
of all lower limb amputations. Globally, there is an am-
putation every 30 s due to a non-healing diabetic ulcer
[19]. The 5-year mortality rate following amputation is
reported to be between 40 and 70% [20] and is higher
among patients with major amputation [21]. Unfortu-
nately, events such as infections, amputations and death
as a consequence of a wound are all too common and
may be avoidable with accurate diagnosis and early ap-
propriate treatment.
The ageing populations in many parts of the world
and the increasing incidence of chronic diseases make
the requirement for improved wound care urgent and
critical. However, to enable effective implementation,
there needs to be greater awareness about the increasing
clinical challenge that wounds present, and methodology
needs to be developed to ascertain and ensure that cost-
effective clinical practices are employed. Currently, there
is a lack of research on the humanistic and economic
burden of chronic wounds and there is consequently a
need to comprehensively quantify the burden of chronic
wounds to the individual and healthcare system.
An improved knowledge would equip decision makers
with a tool for evaluating therapies and an increased un-
derstanding of what drives a cost-effective wound care.
Accurate and robust measurement of disease burden is
therefore imperative for the future planning of health-
care services and optimisation of clinical pathways. The
development of new knowledge and innovative tech-
nologies, and the widespread adoption of these develop-
ments into best practice clinical pathways is also
required if a more effective wound care is to be
achieved. There are great challenges ahead. A systematic
review published in 2014 has shown that few cost-
effectiveness studies exist to guide decision makers re-
garding guideline-based or strategic interventions for
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chronic wounds [22]. However, existing evidence point
in the direction that more specialised and intense wound
care is cost-effective and not rarely cost-saving [23].
Moreover, a Danish study has argued that by adopting a
national strategy based on best practice guidelines, it
may be possible to reduce the costs for wound manage-
ment with up to 30% [24].
A systematic review of the humanistic and economic
burden of chronic wounds is essential for policy and
planning purposes, to monitor trends in disease burden
and not at least in order to estimate the real-world cost-
effectiveness of new treatments and therapies. The in-
creasing number of elderly and the increasing prevalence
of lifestyle diseases such as obesity and diabetes will re-
sult in that the burden of chronic wounds will be con-
siderably larger if nothing is made. New treatments,
therapies and preventive interventions require cost-
effectiveness studies that would benefit hugely from
burden-of-disease estimates.
The systematic review’s outcome consists of data on
quality of life and cost consequences for pressure ulcers,
diabetic ulcers, venous ulcers and arterial insufficiency
ulcers. Quality of life or health-related quality of life
(HRQoL) is a patient-reported outcome (PRO) which
means that it is a report of the status of a patient’s health
condition that comes directly from the patient, without
interpretation of the patient’s responses by a physician
or anyone else. Common HRQoL measures include
EuroQol (EQ-5D), Short-Form 36 (SF-36), health util-
ities index (HUI) and the visual analogue scale (VAS).
The economic definition of cost is the value of oppor-
tunity forgone, strictly the best opportunity forgone, as a
result of engaging resources in an activity, in this case,
the care of chronic wounds. Costs do also arise without
the exchange of money and extends beyond those falling
on the healthcare service alone, e.g. patients themselves
and families, caregivers and communities.
The overall aim of this paper is to present a transpar-
ent process for how the information will be collected on
the humanistic and economic burden of chronic wounds
and related complications. This will include the key re-
search questions that this review will address description
of systematic literature search strategies, criteria for in-
clusion or exclusion of studies, description of coding
procedures, study quality measures and statistical proce-
dures for the quantitative analysis of data from eligible
studies.
Methods/design
Protocol
The methods for this systematic review have been de-
veloped according to the recommendations from the
Preferred Reporting Items for Systematic Review and
Meta-Analysis Protocols (PRISMA-P) 2015 statement
[25]. This systematic review protocol has been regis-
tered in the International Prospective Register of Sys-
tematic reviews (PROSPERO): CRD42016037496). A
PRISMA-P file is attached (see Additional file 1).
Research questions
The overall objective is to determine the burden of
chronic wounds and related complications. The focus is
on chronic wounds in the categories of pressure ulcers,
diabetic ulcers, venous ulcers and arterial insufficiency
ulcers.
Specific review questions are as follows:
 What is the impact on the patient’s and carer’s
health-related quality of life of chronic wounds in
the categories of pressure ulcers, diabetic ulcers,
venous ulcers and arterial insufficiency ulcers?
 What is the reported economic impact of chronic
wounds in the categories of pressure ulcers, diabetic
ulcers, venous ulcers and arterial insufficiency
ulcers?
Eligibility criteria
Population
The population of interest will include adult patients
18 years of age and older with pressure ulcers, diabetic
ulcers, venous ulcers and arterial ulcers. Patients with
chronic wounds resulting from non-preventable surgical
wounds and wounds from skin tumours will be
excluded.
Outcome
 Impact on HRQoL for patients and carers of defined
chronic wounds and complications measured either
over different generic domains (e.g. EQ-5D, SF-36,
HUI) or by a single-index health utility measure (e.g.
time trade-off (TTO), standard gamble (SG), visual
analogue scale (VAS)).
 Measured and valued cost consequences of defined
chronic wounds and specified complications thereof.
Measured and valued cost consequences could be
either incidence or prevalence based.
Study design
Studies will be restricted by design and observational
studies, cross-sectional studies, cohort studies, case-
control studies, single arm and systematic review/meta-
analyses will be included.
Non-research letters and editorials, seminar reviews
and case studies/series reporting cases will be excluded.
Studies reporting health-related quality of life will be re-
stricted to include studies that measures patient-
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reported generic HRQoL and studies that measures dis-
ease specific HRQoL will consequently be excluded.
Randomised controlled trials will be excluded based
on methodological inappropriateness of research design
for the type of questions to be answered. Economic
modelling studies will be excluded as they present data
for costs or cost-effectiveness related to specific inter-
ventions under investigation.
Search strategy
We will begin by developing a comprehensive database
containing empirical studies evaluating, describing or
comparing measurement of quality of life and/or the
economic impact of chronic wounds (including hard-to-
heal wound/ulcers) and complications thereof in general
populations. A systematic search of MEDLINE (Ovid),
EMBASE (Ovid), EBM Reviews and Cochrane (Ovid),
Cumulative Index to Nursing and Allied Health Litera-
ture (CINAHL) (EBSCO), PsycINFO (EBSCO) and Glo-
bal Health (EBSCO) will be undertaken. As we are
primarily interested in the contemporary literature on
this topic, we will examine publications from January
2000 through December 2015.
To construct a comprehensive set of possible search
terms, we list indexing terms (for example, subject head-
ings and subheadings, publication types) and text words
used to describe concept clusters (single words or
phrases that may appear in titles or abstracts, both in
full and in various truncations). For instance, we search
pressure ulcer with its keyword “pressure ulcer” with all
heading and subheadings, and then we search alternative
keywords “pressure sore” or “bed ulcer” or “bed sore”
appearing in the title or abstract in the form of full or
truncations. We sought further terms from clinicians
and librarians, and from published strategies from other
groups. The search strategy was developed by the re-
search team in collaboration with an experienced med-
ical research librarian at the Lee Kong Chian School of
Medicine. Additional comments and suggestions were
also received from an experienced librarian at the
Karolinska Institutet and incorporated. The search was
revised, as necessary, and the final MEDLINE search is
presented in Additional file 2. The MEDLINE strategy
will be adapted to the syntax and subject headings of
other databases.
Searches will be limited to peer-reviewed full text arti-
cles in English language and letters, abstracts, and edito-
rials are to be excluded. There will be no geographical
limitation on the included studies. Contact with authors
for further information will be made when necessary.
The reference lists of all identified articles from January
2000 and beyond will also be searched for any additional
sources of information. An additional search will be
made using the newly introduced term “pressure injury”
[26] and relevant articles added.
Study records
Data management
We will implement the search strategies and import all
references identified to EndNote. The search results
from the different electronic databases will be combined
in a single EndNote library and we will remove duplicate
records of the same reports.
Selection process
Two reviewers will independently screen titles and ab-
stracts against eligibility criteria to identify potentially
included studies. Specifically, titles and abstracts are in-
cluded if they indicate that it was a population-based or
institutional-based study reporting any relevant informa-
tion on the humanistic or economic burden of chronic
wounds and/or complications thereof. In the next phase,
we will retrieve full-text copies of those articles deemed
potentially relevant. Two reviewers will independently
assess the full text of the retrieved articles for compli-
ance with our eligibility criteria. Discrepancies between
the two reviewers’ judgement will be resolved by discus-
sion or by the involvement of a third reviewer. Studies,
which appeared to be relevant, but excluded at this stage
will be listed in the table “Characteristics of excluded
studies”, where a reason for exclusion will be noted.
Two reviewers will verify the final list of included stud-
ies. A PRISMA flow diagram of the study selection pro-
cedure will be prepared to provide an overview of the
decisions that are made in the data collection process.
Data collection process
Two reviewers will independently extract and manage
the data for each of the included studies using an elec-
tronic data extraction form. We will pilot the data ex-
traction form and amend it according to feedback
received from a panel of experienced colleagues. We
plan to contact study authors in case of any unclear or
missing information. Disagreements between review au-
thors will be resolved by discussion. A third review au-
thor will act as an arbiter in case disagreements cannot
be resolved.
Data items
Data will be extracted on the following:
1. Publication details: title, journal, author, year, city
and country, in which the study was conducted, type
of publication, and source of funding.
2. Design: type of study (observational studies, cross-
sectional, cohort, case-control, single arm, systemic
review/meta-analyses); aims of study, method of data
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collection, response rate, recruitment methods, eligi-
bility (inclusion and exclusion criteria).
3. Study participant details: number of persons
interviewed or surveyed, population characteristics
including age, gender, ethnicity, demographic
information, diagnostics, ulcer specifications,
complications.
4. Data for outcome measures. Humanistic burden:
utility score patient, utility score carer, utility
instrument/method applied, scoring algorithm,
mode of administration, utility control patient, utility
control carer, limitations in the measurement of
utility. Economic burden: cost currency, cost
sources, whether prevalence-based COI or
incidence-based COI, recall period, mode of admin-
istration, discounting (incidence-based), cost in-
patient care, cost outpatient specialist care, cost
primary care, cost pharmaceuticals, cost community
care, cost aid/utensils, cost productivity losses, prod-
uctivity loss, method of estimation, productivity loss,
per cent of full working time, cost informal care,
method of estimation, informal care per cent of full
working time, limitations/needed improvements.
The primary outcome will be impact on HRQoL by
category of ulcers and associated direct and indirect
costs. Differences in applied methodologies, ulcer speci-
fications and other uncertainties will clearly be
accounted for. Conservative valuations of costs and im-
pact on HRQoL will be prioritised. Variations that may
depend on age distribution, the categorisation of ulcer,
study design etc. will be described clearly. Secondary
outcomes will be the impact on carers’ HRQoL, drop-
ping out and the reasons for that.
Risk of bias in individual studies
As a variety of study types and data sources are likely to
be eligible from the literature, information will be re-
corded on the appropriateness of the particular study
design to estimate relevant parameters and the represen-
tativeness of the population. There are many sources for
methodological biases starting from research question it-
self, selection bias, information bias, confounding and
overall quality of a study. Therefore, studies reporting
health-related quality of life will be critically appraised
using the Joanna Briggs Institute critical appraisal tool
which is developed for prevalence data but also suitable
for quality of life data that is collected with validated
and well-recognised instruments [27]. Studies reporting
the economic burden will be appraised using the
Drummond and Jefferson checklist [28].
The quality assessment will be independently con-
ducted by two reviewers. Any discrepancies will be dis-
cussed, and if required, a third reviewer will be
consulted. Publication bias and selective reporting will
be dealt with by critically assessing study findings, plots
will be made of outcome variables against sample size
[25] and advice will be taken from GRADE guidelines
No. 5 [29].
Data synthesis
For studies on quality-of-life, a hierarchical linear model
will be used to perform a meta-regression in which qual-
ity of life is the independent variable while elicitation
method, respondents’ characteristics, instrument, cat-
egory of wound and wound duration will be tested as ex-
planatory variables.
Meta-analysis of international cost data is difficult be-
cause of transferability due to geographic origin. How-
ever, all costs will be presented in the reference year of
2015 in US dollars using the consumer price index (CPI)
for each country [30] and the year 2015 purchasing
power parity (PPP) conversion factor [31, 32] to allow
for greater transparency and comparability across
studies.
Statistical analysis
Descriptive analysis will be performed based on the col-
lective information from the studies and summarised
into tables. The forest plots will be made for quality of
life and cost data indicators with their 95% confidence
intervals (C.I.s) to visualise publication bias. Further, the
subgroup analysis and sensitivity analysis will also be
performed to address the variability across studies. If the
collective evidence of studies allowed, the study out-
comes will be further stratified according the back-
ground outcome variables. Choice of meta-analysis will
also be based on the homogeneous group of studies. For
studies on quality of life (QOL), a hierarchical linear
model will be used to perform a meta-regression in
which quality of life is the independent variable while
elicitation method, respondents, instrument etc. could
be explanatory variables. Parametric meta-analyses may
be considered for cost data based on the number of the
eligible studies. The decision of fixed effect model will
be based on pooled data using the appropriate statistical
method and the choice of random-effects model will be
based on clinical and methodological diversity across the
included studies
Summary
This systematic review will be performed to critically
examine the world’s relevant literature on the humanis-
tic and economic burden of chronic wounds. Specific-
ally, we aim to identify and report the estimated
humanistic and economic burden of chronic wounds in
the categories of pressure ulcers, diabetic ulcers, venous
ulcers and arterial insufficiency ulcers and related
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complications for different settings and subgroups. Un-
derstanding the humanistic and economic impact bur-
den of different categories of complications among
patients with chronic wounds could inform policy
makers on the cost effectiveness of implementing early
screening and other prevention or treatment efforts.
Also, quantifying the humanistic and economic burden
of chronic wounds will help guide decision-making for
the allocation of scarce healthcare resources and fund-
ing. A further finding of this systematic review will be
the methodological assessment of the published litera-
ture. The findings of this review will also be compared
with other similar published reviews. Finally, conclusions
will be drawn from this systematic review highlighting
the burden of chronic wounds, methods of estimation
and settings and their correlates. Limitations of the stud-
ies will be discussed in detail. Implications of the review
as well as suggestions for future research will also be
provided.
Additional files
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Additional file 2: MEDLINE search strategy. (DOCX 32 kb)
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